MORN— AI Stock Forecast & Price Targets
Published 7/23/2026 · A free sample of K3vl4r’s AI-powered analysis.
Kronos price forecasts, scored fundamentals & technicals, and a multi-horizon plan.
View the live MORN price forecast →
Morningstar is a high-quality data/analytics franchise (30.7% ROE, 62% GM, $453M TTM FCF) trading at 12.4x forward EPS and 0.71 PEG after a -42% drawdown from 52W highs, but the July 29 earnings print (6 days out) is a binary catalyst that dominates near-term risk/reward. Confirmation of the Q1'26 24.2% operating margin trajectory and clarity on the $865M debt build is required to unlock the re-rating; the stock is a pre-earnings accumulate but not a position to size aggressively into the print.
Pre-earnings accumulate ONLY, with explicit sizing discipline. The July 29 AMC print is 6 days out and is a binary event with likely $10-15 gap risk (ATR $7.34). Take a starter position (25-33% of intended size) between $164-168, with a hard stop below $158 pre-earnings. Do NOT add into the print. Key upside gate: sustained close above $173 signals reversal; next resistance $180/$185. Invalidation: break below $155 pre-earnings, or a Q2 print showing operating margin below 22% and/or no clear disclosure of the debt bridge. Earnings stance: neutral-to-constructive but explicitly NOT a size-up-into-print trade.
1-6 month view is ACCUMULATE with $190 base and $215 bull, contingent on the July 29 print. If Q2 confirms operating margin ≥23-24% and management provides a clean bridge for the $865M debt build (CRSP + buybacks + refinancing), the stock should re-rate toward $190 (12% upside) as the market prices back in the high-quality franchise at 14x forward EPS. Sell-side target of $226 and PEG 0.71 both leave room. What would change my mind: operating margin miss below 22%, working capital drag persisting into Q2 (FCF <$100M), or forward guidance cut below the ~7% earnings growth path.
1-3 year thesis is that MORN is a durable recurring-revenue data monopoly with three compounding legs — PitchBook (private markets data), Morningstar Indexes (CRSP + CME derivatives licensing = AUM-linked royalty stream), and Retirement/Wealth (fiduciary/managed accounts). At 30.7% ROE and low-teens forward P/E, this is a compounder trading at a discount to its own history. Multi-year drivers: CRSP index integration into Vanguard's ETF platform is a genuine annuity, PitchBook 'Time to Exit' ML monetization extends the moat, and the Sustainalytics ESG franchise remains a call option. Biggest structural risk: secular pricing pressure from Bloomberg/FactSet/S&P Global on the terminal/data business, and AI-driven disintermediation of research subscriptions — MORN needs to prove it is on the buy-side of the AI shift, not the sell-side.
Revenue trajectory remains healthy with Q1'26 at $644.8M (+10.8% YoY vs Q1'25 comparable, +0.6% sequential from $641.1M in Q4'25), and margins have inflected meaningfully — Q1'26 operating margin hit 24.2% vs 20.7% in Q3'25 and 20.7% in Q2'25, with gross margin expanding to 63.0%. ROE of 30.7% and ROA of 10.6% mark this as a genuinely high-quality franchise, and $453M TTM FCF against a $6.35B market cap gives ~7% FCF yield. However, the balance sheet raises real questions: total debt jumped from $1.03B in Q2'25 to $1.91B in Q1'26 while stockholders' equity contracted from $1.61B to $1.02B — a ~$865M debt build against a ~$596M equity decline. Some of this is explained by the $363M CRSP acquisition and $300M buyback, but the full bridge needs disclosure. Q1'26 FCF of $53.6M is materially weaker than Q4'25 ($161M) and Q3'25 ($160M), reflecting working-capital drag. Debt/Eq of 1.87 and current ratio of 1.03 mean leverage now matters. Capital allocation has been aggressive (buybacks + M&A) — the question is whether the operating leverage justifies it.
The stock is broken on longer timeframes: down -23% YTD, -40% year-over-year, -42% from the 52W high of $289.63, and trading -12.3% below the 200-day SMA. It sits -2.3% below the 50-day but +1.5% above the 20-day, so short-term momentum has turned mildly constructive within a broken longer-term trend. RSI at 48.7 is neutral — no oversold bounce setup, no overbought risk. On the 1h chart the stock has stabilized in the $164–168 range after basing near $155–158; the model's 1h forecast projects $190.75 which is aggressive against the current $166.83 print. The 4h forecast at $189.44 and 1d forecast at $208 lean uniformly bullish but the model's realized 1d accuracy (76%) is BELOW naive baseline (84%), meaning the near-term forecast should be discounted. Key gates: $173 must clear to confirm reversal; $180/$185 are the next resistance shelves; $155 is the recent floor and a break there opens $141 (52W low). ATR of $7.34 implies the earnings gap could easily be $10-15 in either direction.
The signal-heavy news items are corporate: launch of the US Capital Allocation Leaders Index (July 22) with Global X adopting it for the CPTL ETF, and PitchBook winning Best Alternative Data Provider at Waters Technology Rankings — both extend the recurring/index-linked revenue moat consistent with the CRSP and CME licensing storylines. Morningstar's Q3 outlook piece (July 14) got syndicated pickup, reinforcing brand utility. The dominant catalyst overshadowing all of this is the July 29 Q2 earnings print (AMC), where consensus is $2.83 EPS. The one L2 bearish signal is the analyst rating drift from 1.00 to 1.67 over ~45 days (still Buy but softer), which mirrors the -23% YTD price action. Retail sentiment is 100% bullish among tagged messages but volume is thin (15 messages) and reads as a contrarian yellow flag rather than green. No 8-K activity of consequence in the last 30 days beyond a June 25 Reg FD/guidance item.
- Morningstar US Capital Allocation Leaders Index launched July 22 with Global X adopting it for the renamed CPTL ETF — recurring index-licensing revenue extension
- PitchBook named Best Alternative Data Provider (Waters Technology 2026) — reinforces pricing power and enterprise data-platform moat
- CRSP acquisition ($363M in Q1'26) integrates into Vanguard ETF/mutual fund ecosystem, adding durable AUM-linked royalty revenue
- CME Group multi-year derivatives licensing on Morningstar equity indexes — new recurring exchange-linked revenue stream
- Q1'26 operating margin inflection to 24.2% (vs 20.7% in Q2/Q3'25) — if durable, drives the primary re-rating lever
- $300M share repurchase in Q1'26 reducing share count and supporting EPS growth
- Morningstar DBRS credit ratings and Sustainalytics ESG both remain optionality on secular growth in private credit and ESG allocation
- July 29 earnings is a binary catalyst 6 days out — an operating margin miss below 22% or soft guidance could gap the stock to $150-155
- Debt build from $1.03B (Q2'25) to $1.91B (Q1'26) alongside equity contraction from $1.61B to $1.02B needs explicit disclosure — balance sheet quality is the unresolved question
- Q1'26 FCF of $53.6M was materially weaker than $161M/$160M in prior two quarters — working capital drag must reverse in Q2 to validate the FCF durability thesis
- Trend is broken on longer timeframes: -42% from 52W high, -12.3% below 200-day SMA, -23% YTD — technical damage requires a fundamental catalyst to repair
- Model's 1d directional accuracy (76%) is BELOW naive baseline (84%) — near-term price forecasts should be discounted
- Analyst rating drift from 1.00 to 1.67 over ~45 days indicates sell-side caution has crept in
- Secular AI-driven disintermediation risk to the research/terminal subscription business — competitive pressure from Bloomberg, FactSet, S&P Global
- Short float of 8.58% (short ratio 3.34) reflects real bearish positioning heading into the print
Get AI analysis on any stock
This is one of hundreds of Kronos AI reports — scored fundamentals & technicals, bull/base/bear price targets, a multi-horizon plan, and continuously-updated forecasts across the market. Create a free account to explore them all.
Create your free account →Already a member? Sign in · Join our Discord